Finanorm 5 mg tabletki powlekane Polska - polski - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

finanorm 5 mg tabletki powlekane

pharmaswiss ceska republika s.r.o. - silica colloidalis anhydrica; finasteridum - tabletki powlekane - 5 mg

Firmagon Unia Europejska - polski - EMA (European Medicines Agency)

firmagon

ferring pharmaceuticals a/s - degareliks - nowotwory stercza - terapia endokrynologiczna - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.